Home > Resources > Whitepapers > Antimicrobial Resistance Benchmark 2018

Antimicrobial Resistance Benchmark 2018

August 15, 2017

The global healthcare system depends on appropriate and timely access to antimicrobials. Without antibiotics, there is no direct treatment for infections, no safe surgery, no emergency medicine. The unchecked rise of Antimicrobial Resistance (AMR) puts this at risk for us all. While AMR results from natural selection, the ways we make, use and dispose of antimicrobials are undoubtedly accelerating its spread. To address AMR, a fine balance must be struck between appropriate access to antimicrobials and efforts to curb overuse and misuse. Novel antimicrobials and vaccines are also urgently needed.

Spotlight

Imaxio

IMAXIO is an integrated biotech company focused on immunology. It owns a pipeline of vaccines composed marketed, clinical-stage and preclinical-stage products:

OTHER WHITEPAPERS

Vendor Partnering in a Bioprocess Manufacturing and Supply Chain Ecosystem

whitePaper | August 30, 2022

Supply constancy, cost, sterility – even a subset of the factors that impact materials selection can be daunting for biopharmaceutical companies embark.

2022 Biosimilars Report: The U.S. Journey and Path Ahead

whitePaper | June 8, 2022

Cardinal Health is fortunate to sit at the crossroads of the United States (U.S.) healthcare system, engaging with stakeholders from across the industry including healthcare

Imaweld® heat sealable & weldable tube bioprocess media

whitePaper | February 3, 2023

Imaweld® is thermoplastic elastomer tubing particularly designed to transfer critical fluid in pharmaceutical and biopharmaceutical applications.

Mainstreaming Cell & Gene Therapies

whitePaper | October 27, 2022

The cell and gene therapy (CGT) market is rapidly transitioning from ultra-niche cutting-edge science to approved and available therapies that can address previously intractable and often devastating diseases.

Using Clinical Breakpoints to Improve Antimicrobial Resistance Detection

whitePaper | December 13, 2022

Define the ongoing pandemic of antimicrobial resistance. Discuss how we can address the ongoing pandemicin the Clinical Microbiology Laboratory

Making the Promise of mRNA a Reality: OvercomingScale-Up Challenges

whitePaper | March 22, 2023

If scaling issues strike you as obvious or even boring, you should read “On Being the Right Size,” a 1926 essay by geneticist J.B.S. Haldane. It makes the case that a difference in scale—a seemingly simple matter—may demand subtle changes in form and function.

Spotlight

Imaxio

IMAXIO is an integrated biotech company focused on immunology. It owns a pipeline of vaccines composed marketed, clinical-stage and preclinical-stage products:

Events

8th International Conference on Bio-Sensing Technology

Conference

8th International Conference on Bio-Sensing Technology

Conference